RS

Rubi Singh

Active Director Director DIN 08551868
DIN 08551868 First appointment Sep 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Rubi Singh

Data last updated:

Rubi Singh is a Director at Crayol Pharmaceutical Private Limited (since 2019). The company operates in Pharma. Crayol Pharmaceutical Private Limited reported revenue of ₹1.9 Lakh (FY 2020).

DIN 08551868
Primary Designation Director
Industry Pharma
First Appointment 02 Sep 2019
Oldest Company Age 8 yrs
Largest company Crayol Pharmaceutical Private Limited · ₹1.9 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Sep 20192018₹1.9 Lakh (FY 2020)Active

Board colleagues of Rubi Singh

Directorship timeline

Open interactive timeline →
Crayol Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rubi Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rubi Singh

Rubi Singh currently holds 1 directorship: Crayol Pharmaceutical Private Limited (Director, since 02 Sep 2019, revenue ₹1.9 Lakh (FY 2020)).

Rubi Singh was first appointed on 02 Sep 2019 as Director at Crayol Pharmaceutical Private Limited.

The current boards of Rubi Singh's companies include Prabhat Khanna (Crayol Pharmaceutical Private Limited), Shashibhan Shukla (Crayol Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available